Herein, we described that the risk of gynecological cancer was associated with MSH2 (log-rank test MLH1 vs. MSH2 p = 0.02) while no significant difference in CRC risk according to genotype was found (Figure 4C, Table 4). The gene discussed is MLH1; the disease is female reproductive organ cancer.